{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:40:15Z","timestamp":1791286815003,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T00:00:00Z","timestamp":1712620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T00:00:00Z","timestamp":1712620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr Metab (Lond)"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Body composition and body fat distribution are important predictors of cardiometabolic diseases. The etiology of cardiometabolic diseases is heterogenous, and partly driven by inter-individual differences in tissue-specific insulin sensitivity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>To investigate (1) the associations between body composition and whole-body, liver and muscle insulin sensitivity, and (2) changes in body composition and insulin sensitivity and their relationship after a 12-week isocaloric diet high in mono-unsaturated fatty acids (HMUFA) or a low-fat, high-protein, high-fiber (LFHP) diet.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This subcohort analysis of the PERSON study includes 93 individuals (53% women, BMI 25\u201340\u00a0kg\/m2, 40\u201375 years) who participated in this randomized intervention study. At baseline and after 12 weeks of following the LFHP, or HMUFA diet, we performed a 7-point oral glucose tolerance test to assess whole-body, liver, and muscle insulin sensitivity, and whole-body magnetic resonance imaging to determine body composition and body fat distribution. Both diets are within the guidelines of healthy nutrition.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>At baseline, liver fat content was associated with worse liver insulin sensitivity (\u03b2 [95%CI]; 0.12 [0.01; 0.22]). Only in women, thigh muscle fat content was inversely related to muscle insulin sensitivity (-0.27 [-0.48; -0.05]). Visceral adipose tissue (VAT) was inversely associated with whole-body, liver, and muscle insulin sensitivity. Both diets decreased VAT, abdominal subcutaneous adipose tissue (aSAT), and liver fat, but not whole-body and tissue-specific insulin sensitivity with no differences between diets. Waist circumference, however, decreased more following the LFHP diet as compared to the HMUFA diet (-3.0 vs. -0.5\u00a0cm, respectively). After the LFHP but not HMUFA diet, improvements in body composition were positively associated with improvements in whole-body and liver insulin sensitivity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Liver and muscle insulin sensitivity are distinctly associated with liver and muscle fat accumulation. Although both LFHP and HMUFA diets improved in body fat, VAT, aSAT, and liver fat, only LFHP-induced improvements in body composition are associated with improved insulin sensitivity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>NCT03708419 (clinicaltrials.gov).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12986-024-00795-y","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T11:02:02Z","timestamp":1712660522000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Body composition and body fat distribution in tissue-specific insulin resistance and in response to a 12-week isocaloric dietary macronutrient intervention"],"prefix":"10.1186","volume":"21","author":[{"given":"Inez","family":"Trouwborst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly M.","family":"Jardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anouk","family":"Gijbels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabby","family":"Hul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith J.M.","family":"Feskens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia A.","family":"Afman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Linge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gijs H.","family":"Goossens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen E.","family":"Blaak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,9]]},"reference":[{"issue":"3","key":"795_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000471488","volume":"10","author":"GH Goossens","year":"2017","unstructured":"Goossens GH. The metabolic phenotype in obesity: Fat Mass, Body Fat distribution, and adipose tissue function. Obes Facts. 2017;10(3):207\u201315.","journal-title":"Obes Facts"},{"issue":"7","key":"795_CR2","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1038\/oby.2011.36","volume":"19","author":"J Gomez-Ambrosi","year":"2011","unstructured":"Gomez-Ambrosi J, Silva C, Galofre JC, Escalada J, Santos S, Gil MJ, et al. Body adiposity and type 2 diabetes: increased risk with a high body fat percentage even having a normal BMI. Obes (Silver Spring). 2011;19(7):1439\u201344.","journal-title":"Obes (Silver Spring)"},{"key":"795_CR3","doi-asserted-by":"crossref","unstructured":"Blaak EE. Current metabolic perspective on malnutrition in obesity: towards more subgroup-based nutritional approaches? Proc Nutr Soc. 2020:1\u20137.","DOI":"10.1017\/S0029665120000117"},{"issue":"2","key":"795_CR4","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/ijo.2011.100","volume":"36","author":"J Gomez-Ambrosi","year":"2012","unstructured":"Gomez-Ambrosi J, Silva C, Galofre JC, Escalada J, Santos S, Millan D, et al. Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. Int J Obes (Lond). 2012;36(2):286\u201394.","journal-title":"Int J Obes (Lond)"},{"issue":"11","key":"795_CR5","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1002\/oby.22210","volume":"26","author":"J Linge","year":"2018","unstructured":"Linge J, Borga M, West J, Tuthill T, Miller MR, Dumitriu A, et al. Body composition profiling in the UK Biobank Imaging Study. Obes (Silver Spring). 2018;26(11):1785\u201395.","journal-title":"Obes (Silver Spring)"},{"key":"795_CR6","doi-asserted-by":"crossref","unstructured":"Kusters YH, Schalkwijk CG, Houben AJ, Kooi ME, Lindeboom L, \u2018t Op J et al. Independent tissue contributors to obesity-associated insulin resistance. JCI Insight. 2017;2(13).","DOI":"10.1172\/jci.insight.89695"},{"issue":"Suppl 2","key":"795_CR7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1467-789X.2012.01033.x","volume":"13","author":"MJ Muller","year":"2012","unstructured":"Muller MJ, Lagerpusch M, Enderle J, Schautz B, Heller M, Bosy-Westphal A. Beyond the body mass index: tracking body composition in the pathogenesis of obesity and the metabolic syndrome. Obes Rev. 2012;13(Suppl 2):6\u201313.","journal-title":"Obes Rev"},{"key":"795_CR8","doi-asserted-by":"crossref","unstructured":"Tejani S, McCoy C, Ayers CR, Powell-Wiley TM, Despres JP, Linge J et al. Cardiometabolic Health Outcomes Associated With Discordant Visceral and Liver Fat Phenotypes: Insights From the Dallas Heart Study and UK Biobank. Mayo Clin Proc. 2021.","DOI":"10.1016\/j.mayocp.2021.08.021"},{"key":"795_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fnut.2018.00077","volume":"5","author":"I Trouwborst","year":"2018","unstructured":"Trouwborst I, Bowser SM, Goossens GH, Blaak EE. Ectopic Fat Accumulation in distinct insulin resistant phenotypes; targets for Personalized Nutritional interventions. Front Nutr. 2018;5:77.","journal-title":"Front Nutr"},{"issue":"1","key":"795_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41574-020-00431-8","volume":"17","author":"GH Goossens","year":"2021","unstructured":"Goossens GH, Jocken JWE, Blaak EE. Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver. Nat Rev Endocrinol. 2021;17(1):47\u201366.","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"795_CR11","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/oby.20191","volume":"21","author":"AM Goss","year":"2013","unstructured":"Goss AM, Goree LL, Ellis AC, Chandler-Laney PC, Casazza K, Lockhart ME, et al. Effects of diet macronutrient composition on body composition and fat distribution during weight maintenance and weight loss. Obes (Silver Spring). 2013;21(6):1139\u201342.","journal-title":"Obes (Silver Spring)"},{"issue":"1","key":"795_CR12","doi-asserted-by":"publisher","first-page":"S177","DOI":"10.3945\/jn.114.195065","volume":"145","author":"BA Gower","year":"2015","unstructured":"Gower BA, Goss AM. A lower-carbohydrate, higher-fat diet reduces abdominal and intermuscular fat and increases insulin sensitivity in adults at risk of type 2 diabetes. J Nutr. 2015;145(1):S177\u201383.","journal-title":"J Nutr"},{"issue":"10","key":"795_CR13","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1017\/S0007114520002019","volume":"124","author":"N Haghighat","year":"2020","unstructured":"Haghighat N, Ashtary-Larky D, Bagheri R, Mahmoodi M, Rajaei M, Alipour M, et al. The effect of 12 weeks of euenergetic high-protein diet in regulating appetite and body composition of women with normal-weight obesity: a randomised controlled trial. Br J Nutr. 2020;124(10):1044\u201351.","journal-title":"Br J Nutr"},{"key":"795_CR14","doi-asserted-by":"crossref","unstructured":"Wali JA, Solon-Biet SM, Freire T, Brandon AE. Macronutrient determinants of obesity, Insulin Resistance and metabolic health. Biology (Basel). 2021;10(4).","DOI":"10.3390\/biology10040336"},{"issue":"1","key":"795_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cmet.2022.12.002","volume":"35","author":"I Trouwborst","year":"2023","unstructured":"Trouwborst I, Gijbels A, Jardon KM, Siebelink E, Hul GB, Wanders L, et al. Cardiometabolic health improvements upon dietary intervention are driven by tissue-specific insulin resistance phenotype: a precision nutrition trial. Cell Metab. 2023;35(1):71\u2013e835.","journal-title":"Cell Metab"},{"key":"795_CR16","doi-asserted-by":"publisher","first-page":"694568","DOI":"10.3389\/fnut.2021.694568","volume":"8","author":"A Gijbels","year":"2021","unstructured":"Gijbels A, Trouwborst I, Jardon KM, Hul GB, Siebelink E, Bowser SM, et al. The PERSonalized glucose optimization through nutritional intervention (PERSON) study: Rationale, Design and preliminary Screening results. Front Nutr. 2021;8:694568.","journal-title":"Front Nutr"},{"issue":"6","key":"795_CR17","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s10654-014-9889-0","volume":"29","author":"MT Schram","year":"2014","unstructured":"Schram MT, Sep SJ, van der Kallen CJ, Dagnelie PC, Koster A, Schaper N, et al. The Maastricht Study: an extensive phenotyping study on determinants of type 2 diabetes, its complications and its comorbidities. Eur J Epidemiol. 2014;29(6):439\u201351.","journal-title":"Eur J Epidemiol"},{"issue":"7","key":"795_CR18","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1002\/oby.22510","volume":"27","author":"J Linge","year":"2019","unstructured":"Linge J, Whitcher B, Borga M, Dahlqvist Leinhard O. Sub-phenotyping metabolic disorders using body composition: an Individualized, Nonparametric Approach Utilizing Large Data Sets. Obes (Silver Spring). 2019;27(7):1190\u20139.","journal-title":"Obes (Silver Spring)"},{"issue":"9","key":"795_CR19","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22(9):1462\u201370.","journal-title":"Diabetes Care"},{"issue":"1","key":"795_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2337\/dc06-1519","volume":"30","author":"MA Abdul-Ghani","year":"2007","unstructured":"Abdul-Ghani MA, Matsuda M, Balas B, DeFronzo RA. Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care. 2007;30(1):89\u201394.","journal-title":"Diabetes Care"},{"issue":"7","key":"795_CR21","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"KG Alberti","year":"1998","unstructured":"Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539\u201353.","journal-title":"Diabet Med"},{"key":"795_CR22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3389\/fendo.2014.00195","volume":"5","author":"AM Lundsgaard","year":"2014","unstructured":"Lundsgaard AM, Kiens B. Gender differences in skeletal muscle substrate metabolism - molecular mechanisms and insulin sensitivity. Front Endocrinol (Lausanne). 2014;5:195.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"795_CR23","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1152\/japplphysiol.91382.2008","volume":"107","author":"L Hoeg","year":"2009","unstructured":"Hoeg L, Roepstorff C, Thiele M, Richter EA, Wojtaszewski JF, Kiens B. Higher intramuscular triacylglycerol in women does not impair insulin sensitivity and proximal insulin signaling. J Appl Physiol (1985). 2009;107(3):824\u201331.","journal-title":"J Appl Physiol (1985)"},{"issue":"5","key":"795_CR24","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1007\/s00125-012-2496-2","volume":"55","author":"S Paul","year":"2012","unstructured":"Paul S, Thomas G, Majeed A, Khunti K, Klein K. Women develop type 2 diabetes at a higher body mass index than men. Diabetologia. 2012;55(5):1556\u20137.","journal-title":"Diabetologia"},{"issue":"1","key":"795_CR25","doi-asserted-by":"publisher","first-page":"e000787","DOI":"10.1136\/bmjdrc-2019-000787","volume":"7","author":"R de Ritter","year":"2019","unstructured":"de Ritter R, Sep SJS, van der Kallen CJH, Schram MT, Koster A, Kroon AA, et al. Adverse differences in cardiometabolic risk factor levels between individuals with pre-diabetes and normal glucose metabolism are more pronounced in women than in men: the Maastricht Study. BMJ Open Diabetes Res Care. 2019;7(1):e000787.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"7","key":"795_CR26","first-page":"3188","volume":"86","author":"G Perseghin","year":"2001","unstructured":"Perseghin G, Scifo P, Pagliato E, Battezzati A, Benedini S, Soldini L, et al. Gender factors affect fatty acids-induced insulin resistance in nonobese humans: effects of oral steroidal contraception. J Clin Endocrinol Metab. 2001;86(7):3188\u201396.","journal-title":"J Clin Endocrinol Metab"},{"key":"795_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-3-319-70178-3_2","volume":"1043","author":"MA Bredella","year":"2017","unstructured":"Bredella MA. Sex differences in body composition. Adv Exp Med Biol. 2017;1043:9\u201327.","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"795_CR28","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.beem.2007.04.007","volume":"21","author":"JC Wells","year":"2007","unstructured":"Wells JC. Sexual dimorphism of body composition. Best Pract Res Clin Endocrinol Metab. 2007;21(3):415\u201330.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"795_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41574-019-0310-7","volume":"16","author":"R Ross","year":"2020","unstructured":"Ross R, Neeland IJ, Yamashita S, Shai I, Seidell J, Magni P, et al. Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on visceral obesity. Nat Rev Endocrinol. 2020;16(3):177\u201389.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"795_CR30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1515\/hmbci-2014-0023","volume":"19","author":"GE Walker","year":"2014","unstructured":"Walker GE, Marzullo P, Ricotti R, Bona G, Prodam F. The pathophysiology of abdominal adipose tissue depots in health and disease. Horm Mol Biol Clin Investig. 2014;19(1):57\u201374.","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"5 Suppl 1","key":"795_CR31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.orcp.2016.12.007","volume":"11","author":"HW Kwon","year":"2017","unstructured":"Kwon HW, Lee SM, Lee JW, Oh JE, Lee SW, Kim SY. Association between volume and glucose metabolism of abdominal adipose tissue in healthy population. Obes Res Clin Pract. 2017;11(5 Suppl 1):133\u201343.","journal-title":"Obes Res Clin Pract"},{"issue":"7","key":"795_CR32","first-page":"537","volume":"36","author":"MC Amato","year":"2013","unstructured":"Amato MC, Guarnotta V, Giordano C. Body composition assessment for the definition of cardiometabolic risk. J Endocrinol Invest. 2013;36(7):537\u201343.","journal-title":"J Endocrinol Invest"},{"issue":"9","key":"795_CR33","doi-asserted-by":"publisher","first-page":"E439","DOI":"10.1002\/oby.20135","volume":"21","author":"IJ Neeland","year":"2013","unstructured":"Neeland IJ, Ayers CR, Rohatgi AK, Turer AT, Berry JD, Das SR, et al. Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults. Obes (Silver Spring). 2013;21(9):E439\u201347.","journal-title":"Obes (Silver Spring)"},{"issue":"9","key":"795_CR34","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/obr.12298","volume":"16","author":"R Stinkens","year":"2015","unstructured":"Stinkens R, Goossens GH, Jocken JW, Blaak EE. Targeting fatty acid metabolism to improve glucose metabolism. Obes Rev. 2015;16(9):715\u201357.","journal-title":"Obes Rev"},{"issue":"6","key":"795_CR35","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/ijo.2010.209","volume":"35","author":"AC Tierney","year":"2011","unstructured":"Tierney AC, McMonagle J, Shaw DI, Gulseth HL, Helal O, Saris WH, et al. Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome\u2013LIPGENE: a European randomized dietary intervention study. Int J Obes (Lond). 2011;35(6):800\u20139.","journal-title":"Int J Obes (Lond)"},{"issue":"1","key":"795_CR36","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00125-015-3776-4","volume":"59","author":"R Blanco-Rojo","year":"2016","unstructured":"Blanco-Rojo R, Alcala-Diaz JF, Wopereis S, Perez-Martinez P, Quintana-Navarro GM, Marin C, et al. The insulin resistance phenotype (muscle or liver) interacts with the type of diet to determine changes in disposition index after 2 years of intervention: the CORDIOPREV-DIAB randomised clinical trial. Diabetologia. 2016;59(1):67\u201376.","journal-title":"Diabetologia"},{"key":"795_CR37","doi-asserted-by":"publisher","first-page":"881877","DOI":"10.3389\/fnut.2022.881877","volume":"9","author":"F Takahashi","year":"2022","unstructured":"Takahashi F, Hashimoto Y, Kaji A, Sakai R, Kawate Y, Okamura T, et al. Dietary Fiber intake is related to skeletal muscle Mass, Body Fat Mass, and muscle-to-Fat ratio among people with type 2 diabetes: a cross-sectional study. Front Nutr. 2022;9:881877.","journal-title":"Front Nutr"},{"issue":"2","key":"795_CR38","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1017\/S0007114512004953","volume":"110","author":"CB Breneman","year":"2013","unstructured":"Breneman CB, Tucker L. Dietary fibre consumption and insulin resistance - the role of body fat and physical activity. Br J Nutr. 2013;110(2):375\u201383.","journal-title":"Br J Nutr"},{"issue":"Suppl 2","key":"795_CR39","doi-asserted-by":"publisher","first-page":"B16","DOI":"10.1016\/j.numecd.2010.12.008","volume":"21","author":"JA Gilbert","year":"2011","unstructured":"Gilbert JA, Bendsen NT, Tremblay A, Astrup A. Effect of proteins from different sources on body composition. Nutr Metab Cardiovasc Dis. 2011;21(Suppl 2):B16\u201331.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"5","key":"795_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jim-2018-000722","volume":"66","author":"M Borga","year":"2018","unstructured":"Borga M, West J, Bell JD, Harvey NC, Romu T, Heymsfield SB, et al. Advanced body composition assessment: from body mass index to body composition profiling. J Investig Med. 2018;66(5):1\u20139.","journal-title":"J Investig Med"},{"key":"795_CR41","doi-asserted-by":"crossref","unstructured":"Tejani S, McCoy C, Ayers CR, Powell-Wiley TM, Despres JP, Linge J et al. Cardiometabolic Health Outcomes Associated With Discordant Visceral and Liver Fat Phenotypes: Insights From the Dallas Heart Study and UK Biobank. Mayo Clin Proc. 2022;97(2):225\u2013\u200937.","DOI":"10.1016\/j.mayocp.2021.08.021"},{"issue":"5","key":"795_CR42","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/s41366-018-0189-8","volume":"43","author":"BW van der Kolk","year":"2019","unstructured":"van der Kolk BW, Vogelzangs N, Jocken JWE, Valsesia A, Hankemeier T, Astrup A, et al. Plasma lipid profiling of tissue-specific insulin resistance in human obesity. Int J Obes (Lond). 2019;43(5):989\u201398.","journal-title":"Int J Obes (Lond)"},{"issue":"12","key":"795_CR43","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.2337\/db19-0560","volume":"68","author":"BW van der Kolk","year":"2019","unstructured":"van der Kolk BW, Kalafati M, Adriaens M, van Greevenbroek MMJ, Vogelzangs N, Saris WHM, et al. Subcutaneous adipose tissue and systemic inflammation are Associated with Peripheral but not hepatic insulin resistance in humans. Diabetes. 2019;68(12):2247\u201358.","journal-title":"Diabetes"},{"key":"795_CR44","doi-asserted-by":"crossref","unstructured":"Vogelzangs N, van der Kallen CJH, van Greevenbroek MMJ, van der Kolk BW, Jocken JWE, Goossens GH et al. Metabolic profiling of tissue-specific insulin resistance in human obesity: results from the Diogenes study and the Maastricht Study. Int J Obes (Lond). 2020.","DOI":"10.1038\/s41366-020-0565-z"}],"container-title":["Nutrition &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-024-00795-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12986-024-00795-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-024-00795-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T11:06:11Z","timestamp":1712660771000},"score":1,"resource":{"primary":{"URL":"https:\/\/nutritionandmetabolism.biomedcentral.com\/articles\/10.1186\/s12986-024-00795-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,9]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["795"],"URL":"https:\/\/doi.org\/10.1186\/s12986-024-00795-y","relation":{},"ISSN":["1743-7075"],"issn-type":[{"value":"1743-7075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,9]]},"assertion":[{"value":"5 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by The Medical Ethics Committee of MUMC+ (NL63768.068.17) and registered at ClinicalTrials.gov (identifier: NCT03708419). All participants provided written informed consent. The study was carried out in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}